2‐(1H‐Benzo‐1,2,3‐triazol‐1‐yl)‐4,4‐di­methyl‐3‐oxo‐N‐phenyl­pentane­thio­amide monohydrate

By  

Acta Crystallographica Section E, Vol. 61, Iss. 5, 2005-05 ,pp. : o1267-o1268

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐(2,4‐Di­hydroxy­phenyl)‐N,N‐di­methyl‐2‐oxoacet­amide

By  

Acta Crystallographica Section E, Vol. 61, Iss. 5, 2005-05 ,pp. : o1505-o1506

John Wiley & Sons Inc

Access to resources Recommend Favorite

[1‐(3‐Amino­propyl)‐4,7‐di­thia‐1‐aza­cyclo­nonane‐κ⁴N,N′,S,S′]­bis­(di­methyl­form­amide‐κO)­nickel(II) bis­(tetra­phenyl­borate) aceto­nitrile disolvate

By  

Acta Crystallographica Section E, Vol. 61, Iss. 2, 2005-02 ,pp. : m207-m208

John Wiley & Sons Inc

Access to resources Recommend Favorite

A monoclinic modification of N‐(3,4‐di­benzoyl‐2,5‐di­methyl­pyrrol‐1‐yl)‐4‐methoxy­benz­amide

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2193-o2194

John Wiley & Sons Inc

Access to resources Recommend Favorite

1′‐(1‐Hydro­xy­ethyl)‐N,N‐di­phenyl­ferrocene‐1‐carbox­amide

By  

Acta Crystallographica Section E, Vol. 61, Iss. 2, 2005-02 ,pp. : m307-m310

John Wiley & Sons Inc

Access to resources Recommend Favorite